Transaction #23505 · Form 4 · 0001193125-25-327280
Lineage Cell Therapeutics, Inc. · Stock award · Common Shares
Lineage Cell Therapeutics, Inc. · Transacted December 19, 2025 · Filed December 19, 2025
What does this filing report?
An SEC Form 4 filing for Lineage Cell Therapeutics, Inc. records a stock award involving Common Shares on December 19, 2025. The reported quantity was 8,925. The filing date is December 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0000876343
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 8,925
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 222,469
- Ownership description
- Not reported
- SEC acceptance time
- Dec 19, 2025, 9:55 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Culley Brian M ↗
President and CEO · Director
CIK 0001310683
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units ("RSUs") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis.
- F2
- Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof.
- F3
- Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 8,925 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.